Ignite Creation Date:
2024-05-05 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00230282
Status:
COMPLETED
Last Update Posted:
2014-10-06
First Post:
2005-09-28
Brief Title:
Phase 2 Fludarabine Cytoxan and FCCAM Alemtuzumab in Untreated B-Cell Chronic Lymphocytic Leukemia
Sponsor:
Organization:
Stanford University